SCHEMBL6982940

SCHEMBL6982940

CCOC(=S)c1cnc(C)nc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DGAT1 O75907 1/20 0.41
▸ CA12 O43570 4/20 0.34
▸ CA1 P00915 4/20 0.34
▸ CA2 P00918 4/20 0.34
▸ CA9 Q16790 4/20 0.34
▸ MAPT P10636 3/20 0.34
▸ CYP2C9 P11712 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ RAB9A P51151 3/20 0.33
▸ CDC7 O00311 1/20 0.32
▸ DBF4 Q9UBU7 1/20 0.32
▸ FOS P01100 1/20 0.31
▸ JUN P05412 1/20 0.31
▸ NFKB1 P19838 1/20 0.31
▸ NFKB2 Q00653 1/20 0.31
▸ RELA Q04206 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ ALDH1A1 P00352 4/20 0.31
▸ PKM P14618 3/20 0.31
▸ MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9591348 0.84 DGAT1 (0.39) DGAT1CA12CA1CA2CA9
SCHEMBL14683910 0.75 DGAT1 (0.41) DGAT1CA12CA1CA2CA9
SCHEMBL2642000 0.75 CYP2C9 (0.53) CA12CA1CA2CA9MAPT
SCHEMBL9684348 0.73 RAB9A (0.37) MAPTRAB9AFOSJUNNFKB1
SCHEMBL2022922 0.72 CSNK1D (0.38) MAPTRAB9ACDC7DBF4FOS
SCHEMBL243274 0.71 ALDH1A1 (0.43) DGAT1MAPTRAB9AFOSJUN
SCHEMBL4717515 0.71 LMNA (0.44) MAPTCYP2C9CYP2C19RAB9ANFKB1
SCHEMBL7456789 0.71 PDK2 (0.32) MAPTFOSJUNNFKB1NFKB2
SCHEMBL8399261 0.71 NFKB1 (0.36) MAPTRAB9AFOSJUNNFKB1
SCHEMBL6621732 0.71 NFKB1 (0.35) MAPTCYP2C9CYP2C19RAB9AFOS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117430591-A Synthesis method of avanafil 康普药业股份有限公司 2024-01-23 — — CN disclosed
CN-106279044-B Pyrimidine hydroxamic acid derivative and preparation method and application thereof 厦门市博瑞来医药科技有限公司 2021-02-19 — — CN disclosed
EP-1093367-A4 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORP (US) 2003-03-05 — — EP disclosed
EP-1093367-A1 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2001-04-25 — — EP disclosed
WO-1999066925-A1 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 1999-12-29 — — WO disclosed
Send feedback